143 related articles for article (PubMed ID: 4005678)
1. Malignant hyperthermia: a possible new variant.
Lee DS; Adams JP; Zimmerman JE
Can Anaesth Soc J; 1985 May; 32(3 Pt 1):268-71. PubMed ID: 4005678
[TBL] [Abstract][Full Text] [Related]
2. [Malignant hyperthermia. III. Progress report on serum CK activity, questionable screening test, effect of dantrolene in family members with a hereditary disposition].
Plötz J
Anaesthesist; 1983 Apr; 32(4):158-64. PubMed ID: 6881517
[TBL] [Abstract][Full Text] [Related]
3. [Transient normalisation of CK blood levels in patients susceptible to malignant hyperthermia by oral administration of dantrolene (author's transl)].
Bernhardt D
Anaesthesist; 1982 May; 31(5):252-4. PubMed ID: 7103034
[TBL] [Abstract][Full Text] [Related]
4. [Oral dantrolene in a parturient with myotonic dystrophy and susceptibility to malignant hyperthermia].
Houvenaeghel M; Achilli-Cornesse E; Jullian-Papouin H; Martin-Meyssonier A; Manelli JC
Ann Fr Anesth Reanim; 1988; 7(5):408-11. PubMed ID: 3207229
[TBL] [Abstract][Full Text] [Related]
5. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
Ward A; Chaffman MO; Sorkin EM
Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
[TBL] [Abstract][Full Text] [Related]
6. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
[TBL] [Abstract][Full Text] [Related]
7. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
8. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.
Britt BA; Endrenyi L; Peters PL; Kwong FH; Kadijevic L
Can Anaesth Soc J; 1976 May; 23(3):263-84. PubMed ID: 938964
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia when dantrolene is not readily available.
Gong X
BMC Anesthesiol; 2021 Apr; 21(1):119. PubMed ID: 33863282
[TBL] [Abstract][Full Text] [Related]
10. Isoenzymes of creatine phosphokinase in serum of families with malignant hyperpyrexia.
Meltzer HY; Hassan SZ; Russo P; Cho HW
Anesth Analg; 1976; 55(6):797-9. PubMed ID: 1033694
[TBL] [Abstract][Full Text] [Related]
11. [Malignant hyperthermia. II. Investigation of the patient's family (author's transl)].
Plötz J
Anaesthesist; 1980 Feb; 29(2):94-8. PubMed ID: 7377529
[TBL] [Abstract][Full Text] [Related]
12. [Atypical course of malignant hyperthermia].
Gumpenberger H
Anaesthesist; 1985 Mar; 34(3):134-6. PubMed ID: 3993899
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia.
Denborough M
Lancet; 1998 Oct; 352(9134):1131-6. PubMed ID: 9798607
[TBL] [Abstract][Full Text] [Related]
14. [Lack of sensitivity to per-anesthetic malignant hyperthermia in 32 patients who developed neuroleptic malignant syndrome].
Bello N; Adnet P; Saulnier F; Lestavel P; Adnet-Bonte C; Reyford H; Etchrivi T; Tavernier B; Krivosic-Horber R
Ann Fr Anesth Reanim; 1994; 13(5):663-8. PubMed ID: 7733515
[TBL] [Abstract][Full Text] [Related]
15. Markedly delayed postoperative malignant hyperthermia.
Souliere CR; Weintraub SJ; Kirchner JC
Arch Otolaryngol Head Neck Surg; 1986 May; 112(5):564-6. PubMed ID: 3954899
[TBL] [Abstract][Full Text] [Related]
16. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative assay of creatine phosphokinase as a precaution against malignant hyperthermia (author's transl)].
Varesi M
Chir Ital; 1978 Dec; 30(6):899-908. PubMed ID: 753545
[TBL] [Abstract][Full Text] [Related]
18. Malignant hyperthermia susceptibility: anaesthetic implications and risk stratification.
Ben Abraham R; Cahana A; Krivosic-Horber RM; Perel A
QJM; 1997 Jan; 90(1):13-8. PubMed ID: 9093584
[TBL] [Abstract][Full Text] [Related]
19. Malignant hyperthermia following preoperative oral administration of dantrolene.
Fitzgibbons DC
Anesthesiology; 1981 Jan; 54(1):73-5. PubMed ID: 7457985
[No Abstract] [Full Text] [Related]
20. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
Schuh FT; Maier C
Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
